193 related articles for article (PubMed ID: 23268645)
21. Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism.
Omote H; Al-Shawi MK
Biophys J; 2006 Jun; 90(11):4046-59. PubMed ID: 16565061
[TBL] [Abstract][Full Text] [Related]
22. Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).
Sharom FJ
Biochem Cell Biol; 2006 Dec; 84(6):979-92. PubMed ID: 17215884
[TBL] [Abstract][Full Text] [Related]
23. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.
Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM
Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232
[TBL] [Abstract][Full Text] [Related]
24. The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence.
Rothnie A; Theron D; Soceneantu L; Martin C; Traikia M; Berridge G; Higgins CF; Devaux PF; Callaghan R
Eur Biophys J; 2001 Oct; 30(6):430-42. PubMed ID: 11718296
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.
Park S; Majd S
PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971
[TBL] [Abstract][Full Text] [Related]
26. Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes.
Abraham EH; Shrivastav B; Salikhova AY; Sterling KM; Johnston N; Guidotti G; Scala S; Litman T; Chan KC; Arceci RJ; Steiglitz K; Herscher L; Okunieff P
Blood Cells Mol Dis; 2001; 27(1):181-200. PubMed ID: 11358379
[TBL] [Abstract][Full Text] [Related]
27. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter.
Romsicki Y; Sharom FJ
Biochemistry; 2001 Jun; 40(23):6937-47. PubMed ID: 11389609
[TBL] [Abstract][Full Text] [Related]
28. The purified and functionally reconstituted multidrug transporter LmrA of Lactococcus lactis mediates the transbilayer movement of specific fluorescent phospholipids.
Margolles A; Putman M; van Veen HW; Konings WN
Biochemistry; 1999 Dec; 38(49):16298-306. PubMed ID: 10587454
[TBL] [Abstract][Full Text] [Related]
29. Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.
Li MJ; Nath A; Atkins WM
Biochemistry; 2017 May; 56(19):2506-2517. PubMed ID: 28441502
[TBL] [Abstract][Full Text] [Related]
30. The conformation and dynamics of P-glycoprotein in a lipid bilayer investigated by atomic force microscopy.
Sigdel KP; Wilt LA; Marsh BP; Roberts AG; King GM
Biochem Pharmacol; 2018 Oct; 156():302-311. PubMed ID: 30121251
[TBL] [Abstract][Full Text] [Related]
31. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
Liu R; Sharom FJ
Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
[TBL] [Abstract][Full Text] [Related]
32. Use of membrane vesicles to investigate drug interactions with transporter proteins, P-glycoprotein and multidrug resistance-associated protein.
Wheeler R; Neo SY; Chew J; Hladky SB; Barrand MA
Int J Clin Pharmacol Ther; 2000 Mar; 38(3):122-9. PubMed ID: 10739115
[TBL] [Abstract][Full Text] [Related]
33. Selectivity of the multidrug resistance modulator, LY335979, for P-glycoprotein and effect on cytochrome P-450 activities.
Dantzig AH; Shepard RL; Law KL; Tabas L; Pratt S; Gillespie JS; Binkley SN; Kuhfeld MT; Starling JJ; Wrighton SA
J Pharmacol Exp Ther; 1999 Aug; 290(2):854-62. PubMed ID: 10411602
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution of drug transport by purified P-glycoprotein.
Shapiro AB; Ling V
J Biol Chem; 1995 Jul; 270(27):16167-75. PubMed ID: 7608182
[TBL] [Abstract][Full Text] [Related]
35. The P-glycoprotein efflux pump: how does it transport drugs?
Sharom FJ
J Membr Biol; 1997 Dec; 160(3):161-75. PubMed ID: 9425600
[TBL] [Abstract][Full Text] [Related]
36. Interaction of LDS-751 with the drug-binding site of P-glycoprotein: a Trp fluorescence steady-state and lifetime study.
Lugo MR; Sharom FJ
Arch Biochem Biophys; 2009 Dec; 492(1-2):17-28. PubMed ID: 19818729
[TBL] [Abstract][Full Text] [Related]
37. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids.
Eckford PD; Sharom FJ
Biochem J; 2005 Jul; 389(Pt 2):517-26. PubMed ID: 15799713
[TBL] [Abstract][Full Text] [Related]
38. A single active catalytic site is sufficient to promote transport in P-glycoprotein.
Bársony O; Szalóki G; Türk D; Tarapcsák S; Gutay-Tóth Z; Bacsó Z; Holb IJ; Székvölgyi L; Szabó G; Csanády L; Szakács G; Goda K
Sci Rep; 2016 Apr; 6():24810. PubMed ID: 27117502
[TBL] [Abstract][Full Text] [Related]
39. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein.
Shapiro AB; Ling V
Eur J Biochem; 1997 Nov; 250(1):122-9. PubMed ID: 9431999
[TBL] [Abstract][Full Text] [Related]
40. ATP hydrolysis by multidrug-resistance protein from Chinese hamster ovary cells.
Senior AE; al-Shawi MK; Urbatsch IL
J Bioenerg Biomembr; 1995 Feb; 27(1):31-6. PubMed ID: 7629049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
